The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.

Anthracycline cardiomyopathy monitored by morphologic changes.

1978 • 589 citations

Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones

1979 • 279 citations

Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.

1979 • 148 citations

Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.

1984 • 63 citations

Safety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. I. Clinical observations.

1982 • 58 citations

Safety assessment of new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology.

1982 • 47 citations

Mitoxantrone versus doxorubicin in advanced breast cancer: A randomized cross-over trial

1983 • 32 citations

Mitoxantrone in acute lymphoblastic leukemia

1983 • 7 citations